BIOBALSAM 0.75 %
METHYL NICOTINATE : 0.75 % CAPSICUM OLEORESIN : 0.05 % · DIN 02230695 · BIOPHARMATECH INC.
Health Canada status: CANCELLED POST MARKET
What is BIOBALSAM?
BIOBALSAM 0.75 % contains METHYL NICOTINATE : 0.75 % CAPSICUM OLEORESIN : 0.05 %. It is listed in the Health Canada Drug Product Database under DIN 02230695, held by BIOPHARMATECH INC., supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 07-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02230695 |
|---|---|
| Brand name | BIOBALSAM |
| Generic / active ingredient | METHYL NICOTINATE : 0.75 % CAPSICUM OLEORESIN : 0.05 % |
| Manufacturer | BIOPHARMATECH INC. |
| Strength | 0.75 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AB CAPSAICIN AND SIMILAR AGENTS |
| AHFS class | 84:24.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 07-Jul-1999 |
| Original market date | 1997-06-04 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code M02AB CAPSAICIN AND SIMILAR AGENTS. 0 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARTHRICARE FOR WOMEN MULTI-ACTION | 1.25 % | CREAM | DEL PHARMACEUTICS (CANADA) INC. | CANCELLED POST MARKET | DIN 01935046 |
| BENEJOINT | 0.025 % | CREAM | LANE LABS-USA, INC. | CANCELLED POST MARKET | DIN 02239488 |
| BORN AGAIN SUPER PAIN RELIEVING LOTION | 0.025 % | LOTION | ALVIN LAST, INC. | CANCELLED POST MARKET | DIN 02236788 |
| CAPSAICIN CREAM 0.025% | .025 % | CREAM | FERNDALE LABORATORIES INC. | CANCELLED POST MARKET | DIN 02185717 |
| CAPSAICIN FORTE CREAM | 0.075 % | CREAM | WEX PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02150123 |
| CAPSAICIN MILD CREAM | 0.025 % | CREAM | WEX PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02150107 |
| CAPSAICIN REGULAR CREAM | 0.05 % | CREAM | WEX PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02150115 |
| CAPSODAN CREAM | 4 % | CREAM | ODAN LABORATORIES LTD | CANCELLED PRE MARKET | DIN 02231073 |
| CAPZASIN-P CREME - 0.025% | .025 % | CREAM | STELLA PHARMACEUTICAL CANADA INC. | CANCELLED POST MARKET | DIN 02174308 |
| FINALGON ONT | 2.5 % | OINTMENT | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00067423 |
Who else supplies CAPSAICIN AND SIMILAR AGENTS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CAPSAICIN AND SIMILAR AGENTS appears in 11 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.